In a new study, scientists at the University of Illinois Chicago (UIC) have maximized the production of extracellular vesicles by simply changing the way donor mesenchymal stem cells (MSC) are cultured. This method opens up new possibilities for research in cell therapy using transplantation of stem cells or immune cells obtained from patients or donors.
Mesenchymal stem cell therapy has helped reduce mortality, the number of heart attacks, and strokes among patients suffering from chronic NYHA functional class II and III heart failure with reduced ejection fraction.
A study by scientists from Cornell University, US, showed that the antimicrobial properties of some proteins produced by mesenchymal stem cells (MSCs) could be used to develop potential treatments for infected wounds.
Scientists from the UNESCO International Society on Aging and Disease (ISOAD) have found that mesenchymal stem cells (MSCs) effectively modulate multiple mechanisms in the human body and restore immune homeostasis in COVID-19 patients.
Mesenchymal stem cells (MSCs) have tremendous potential in regenerative medicine, the goal of which is to repair damaged tissues. However, until now, not much has been known about their in vivo plasticity.
Researchers at the University of Tsukuba, Japan, have found a subpopulation of MSCs that promote bone fracture regeneration and exhibit an increased ability to differentiate into various cell types.
A new phase I clinical trial shows that stem cells can improve patients’ health with lymphedema, a chronic disease affecting up to one in three women treated for breast cancer.
Research on the compassionate use of perivascular umbilical cord tissue (Wharton’s jelly) mesenchymal stem cells (WJ-MSCs) has shown promising results in treating muscular dystrophies. Under the guidance of physicians at the Centrum Medyczne Klara, KMC, Czestochowa, Poland, this procedure significantly improved certain muscle groups in most patients without any severe side effects.
According to a new study, patients with type 2 diabetes who are not overweight and have had the disease for less than ten years may benefit from therapy based on transplantation of mesenchymal stem cells derived from their own bone marrow.
In a groundbreaking new study, a group of scientists from the University of California, Davis, found that a specific type of stem cell can reduce the virus that causes AIDS, increase the body’s antiviral immunity, and repairing lymphoid follicles in the intestines damaged by the simian immunodeficiency virus (SIV), the equivalent of the human immunodeficiency virus (HIV) in non-human primates.
Researchers at the University of Illinois Chicago (UIC) have shown that even after lung damage, fibrosis can be reversed and tissue repair promoted by treatment with microgel-coated mesenchymal stem cells.
Stem cell therapy
- The combination of gene therapy and stem cell therapy has shown long-term success in treating rare skin disease30.12.2021 - 01:34
- Stem cells use fat to fight infection18.12.2021 - 01:04
- Xenobots created a year ago from stem cells have learned to reproduce12.12.2021 - 00:41
- The therapeutic potential of mesenchymal stem cell vesicles could be increased tenfold05.12.2021 - 21:06
Clinic in Kyiv:
+380 67 549 11 61
+380 97 409 91 01
Our representative in Italy:
+99 559 761 43 34
+99 559 996 15 15
Clinic in Prague:
+420 720 087 788
+420 720 097 788